Abacus Wealth Partners, LLC Novartis Ag Transaction History
Abacus Wealth Partners, LLC
- $655 Billion
- Q2 2025
A detailed history of Abacus Wealth Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Abacus Wealth Partners, LLC holds 1,991 shares of NVS stock, worth $263,588. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,991Holding current value
$263,588% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,562Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.41 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.38 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.2 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$1 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$943 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $285B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...